providerNEWSSpring 2018

1

Any policy changes communicated in this newsletter are considered official and effective immediately unless otherwise indicated, and will be reflected in the next edition of the Optima Health Provider Manual.

We have attempted to identify each policy change by placing a red push pin to the left of the corresponding language.

• Colorectal Cancer Screening Program—BioIQ FIT Kit• Optima Community Complete (HMO SNP)• Medallion 4.0

• Medication Linked to Falls• Clinical Guidelines• HEDIS® and Medication Management in the Elderly• HEDIS® 2018 (CY2017) Update• Annual Provider Notices• Member Rights and Responsibilities

• Optima Health Community Care Authorization Forms Online

• Community Mental Health Rehabilitation Services Transition

• Payment of Assessment Services for Optima Health Communuity Care

• Pharmacy Changes Effective April 1, 2018

• Reminder—Complete Your Cultural Competency Training

• Keep Your Practice Information Up to Date

Authorizations and Medical Policies 8

Industry News 5

Pharmacy 10

Important Phone Numbers 17

Provider Resources 6

Quality Improvement 14

Optima Health News 2

Billing and Reimbursement 9

• CMS Requirement for Medicare Providers• Americans with Disabilities Act Compliance• Provider Connection for Centipede Providers• New Website Addresses

2

Colorectal Cancer Screening Program—BioIQ FIT Kit

Colorectal cancer is the third most common cancer in the U.S. in both men and women, and the second leading cause of cancer mortality. Certain areas of Virginia are among those recognized by the Centers for Disease Control and Prevention as communities where colorectal cancer mortality has not kept up with the national trend of earlier detection and decreasing mortality.

To address its unscreened members, Optima Health has implemented a population-based screening project using at-home Fecal Immunochemical Testing (FIT) kits. Annual FIT was recommended by the United States Preventive Services Task Force in their Recommendation Statement1 as equivalent to other screening modalities in life-years gained.

In 2015, Optima Health collaborated with Sentara Quality Care Network (SQCN) physicians to mail almost 1,000 FIT kits to SQCN members non-compliant with colorectal cancer screening recommendations.

• 200 members used the FIT kit to complete their screenings.

• 16 members who used the FIT kit tested positive.

• Follow-up with members who tested positive revealed two members with multiple polyps larger than 1cm, and one member with undiagnosed stage III colon cancer.

To build on the success of the 2015 program, and expand the FIT kit service to all of its unscreened members, Optima Health has partnered with BioIQ—a nationally recognized company that has successfully launched health–testing programs serving millions of members for many healthcare organizations.

In 2017, Optima Health and BioIQ mailed over 10,000 FIT kits to Optima Health members.

• Over 2,000 members used the FIT kit to complete their screening.

• 160 members who used the FIT kit tested positive.

Optima Health News

Sample FIT Kit

continued on page 3 ...

3

Colorectal Cancer Screening Program—BioIQ FIT Kit, continued

BioIQ and Optima Health work collaboratively with members and their primary care physicians (PCP).

• Each member and his/her PCP are notified via mail of the member’s FIT kit results.

• Members who test positive also receive a phone call from an Optima Health-contracted nurse practitioner who educates the member on the importance of following up with a PCP for additional testing.

• Optima Health also contacts the PCP a few weeks after the results are available to ensure that the member has scheduled appropriate follow up.

By collaborating with both members and their PCP, Optima Health is able to monitor member outcomes and receive feedback that helps evaluate the effectiveness of the BioIQ FIT kit program. Most feedback to date has been very positive, and constructive critiques have led to improvements in the program which include expanding access to members already receiving regular screenings. Members are drawn to the convenience of FIT screening; there is no prep or anesthesia required, and the screening can be completed in the comfort of a member’s home.

To sign up for a BioIQ FIT kit, members can visit www.optimahealth.com/colonhealth. For your convenience, Optima Health is also distributing enrollment cards to provider offices.

If you have questions about the program or recommendations to improve it, please contact your Network Educator.

1 Screening for Colorectal Cancer – U.S. Preventive Services Task Force Recommendation Statement. JAMA June 21, 2016 Volume 315, Number 23, pp 2564-2575.

providerNEWS Spring 2018

Optima Health News

4

Optima Community Complete (HMO SNP)

Optima Community Complete (HMO SNP), the Optima Health Medicare Advantage Dual Special Needs Plan (D-SNP)—herein referred to as OCC—became effective January 1, 2018. Membership for OCC is limited to members who participate in the DMAS CCC Plus program. OCC integrates Medicare and Medicaid benefits through care coordination so members receive a more seamless care experience matched to their specific needs.

Members are encouraged, but not required, to enroll in the same health plan for their CCC Plus and D-SNP benefits. Please make sure you obtain both ID cards for these dual-eligible members. The Medicare D-SNP plan is primary, so providers should submit claims directly to Optima Health for OCC members, or the appropriate D-SNP plan for Optima Health Community Care (OHCC) members that are enrolled with another MCO D-SNP plan.

OCC Model of Care training is required for all participating OCC Providers.Providers can meet this training requirement by completing the online OCC Model of Care course available from the Education section of optimahealth.com/providers.

Medallion 4.0

We are pleased to announce that Optima Health has been selected as a Contracted Health Plan for the new DMAS Medallion 4.0 program.

During 2018, Medallion 4.0 will replace Medallion 3.0—the DMAS program that currently includes Optima Family Care (OFC) and FAMIS. Participating Optima Family Care/FAMIS providers do not have to take any action to continue to provide services to OFC/FAMIS members when Medallion 4.0 becomes effective.

On August 1, 2018, DMAS will begin the transition from Medallion 3.0 to Medallion 4.0 in the Tidewater region. The transition from Medallion 3.0 to Medallion 4.0 will continue through December 2018 across the remaining DMAS regions in Virginia.

For further information and proposed transition dates, please view the Medicaid Memo to Providers from January 8, 2018, on the DMAS website.

Optima Health News

55

Reminder—Complete Your Cultural Competency Training

Being equipped to accommodate the needs of an increasingly diverse population is a growing concern in the healthcare community. Cultural competence and effective communication are keys to understanding a patient’s concerns and helping to ensure they understand their healthcare plan.

We strongly encourage all providers to complete cultural competency training. The Optima Health provider directory will display Cultural Competence as a feature on all provider profiles, informing members which providers have completed this important training.

Please visit the Education section of optimahealth.com/providers for links to cultural competency training opportunities. CME credits are available.

Upon completion of training, please complete the Provider Acknowledgement Form for Cultural Competency so we can credit you for this education.

providerNEWS Spring 2018

Industry News

6

CMS Requirement for Medicare Providers

CMS requires all Medicare Managed Care Organizations to verify the accuracy of Medicare Provider Directory information each quarter.

Optima Health utilizes email communications to providers to meet this requirement. Providers must attest to the accuracy of their demographic information (address and phone), and whether or not they are accepting new Optima Medicare HMO or Optima Community Complete (HMO SNP) members.

Please review your directory information in the Find Doctors, Drugs, and Facilities section ofoptimahealth.com/providers. Notify your Network Educator if any corrections are needed. If you have not received an email verifying your information, please notify your Network Educator of your current email address.

Americans with Disabilities Act Compliance

Optima Health Provider Directories are required to indicate whether provider office locations meet accessibility standards in compliance with the Americans with Disabilities Act (ADA). Please inform your Network Educator if your office meets ADA standards so that patients can confirm prior to their appointment if your office is accessible.

Are you receiving emails to verify the accuracy of your directory information with Optima Health?

Please ensure your Optima Health Network Educator has your current email address.

Provider Resources

7

New Website Addresses

We have recently made some changes to optimahealth.com to improve your online experience with us. Some of the website addresses you may have previously used and bookmarked have changed.

To go directly to the provider’s area of optimahealth.com, please visitoptimahealth.com/providers.

If you bookmarked pages to the old version of optimahealth.com, please change those bookmarks so they now will take you to the new version of your favorite pages. If you try to visit an old bookmark and the link does not work, please visitoptimahealth.com/providers to find the new version of the page and bookmark it.

Provider Connection for Centipede Providers

Centipede Providers are encouraged to register for Optima Health Provider Connection. To register, visit optimahealth.com/providers and select Provider Connection Registration from the bottom of the page.

Provider Connection gives you 24/7, web-based access to Optima Health information and services including:

• member eligibility,• authorization status,• detailed claim status, and• the ability to view remits and

pend reports.

Provider Connection is available for all Optima Health providers and also includes additional information and services specific to PCPs, OBs, and other specialties.

providerNEWS Spring 2018

Provider Resources

8

Optima Health Community Care Authorization Forms Online

To access authorization forms for Optima Health Community Care (CCC Plus), visitoptimahealth.com/providers and select Optima Health Community Care Authorization Forms from the Authorizations menu.

Community Mental Health Rehabilitation Services Transition

DMAS is transitioning Community Mental Health Rehabilitation Services (CMHRS) from Magellan to Managed Care Organizations (MCOs).

The first transition was effective January 1, 2018 for CMHRS services provided to DMAS CCC Plus enrollees. The Optima Health CCC Plus plan is Optima Health Community Care (OHCC). All authorizations and claims for CMHRS services for OHCC members after January 1, 2018 should be obtained from or submitted to OHCC.

DMAS created standardized authorization forms for CCC Plus CMHRS services to be used by all participating MCOs. The DMAS standard authorization forms are located at http://www.dmas.virginia.gov/Content_pgs/mltss-trn.aspx. These forms are also available from the Authorizations section ofoptimahealth.com/providers (select Optima Health Community Care Authorization Forms).

CMHRS services for OFC/FAMIS will transition from Magellan to the MCOs as the DMAS change from Medallion 3.0 to Medallion 4.0 is implemented. Until the DMAS transition dates for each region, authorizations and claims for OFC/FAMIS members’ CMHRS services should be obtained from and submitted to Magellan.

Authorizations and Medical Policies

Payment of Assessment Services for Optima Health Community Care

Assessments are required for Therapeutic Day Treatment, Partial Hospitalization, Intensive Community Treatment, Mental Health Skill Building Services, and Psychosocial Rehabilitation. Assessments are NOT required for Mental Health Case Management, Crisis Intervention and Stabilization, or Mental Health Peer Support.

The correct assessment code and modifier must be submitted for payment of assessment services.

Assessment Codes and Modifiers

H0032 U6 – Psychosocial Rehab Assessment

H0032 U7 – Partial Hospitalization Assessment

H0032 U8 – Mental Health Skill Building Assessment

H0032 U9 – Intensive Community Treatment Assessment

H0032 UA – ABA

H0035 HA – TDT

H0035 HB – PHP

H2033 UA – ABA Assessment

9

providerNEWS Spring 2018

Billing and Reimbursement

10

Drug Name Indication Description Change (Standard Formularies)

Description Change (Open Formularies)

Description Change (OHCC

Formulary)

Actemra® IV (tocilizumab)

cytokine release syndrome

ADD as Medical Benefit with Prior Authorization for all Standard Formularies, including Medicaid

ADD as Medical Benefit with Prior Authorization

Actemra® SQ (tocilizumab)

giant cell arteritis ADD to specialty tier with Step-Edit for all Standard Formularies, including Medicaid

ADD to specialty tier with Step-Edit

Benlysta® (belimumab)

systemic lupus erythematosus

UPDATE Prior Authorization criteria for all Standard Formularies, including Medicaid

UPDATE Prior Authorization criteria

Besponsa™ (inotuzumab ozogamicin)

B-cell precursor acute lymphoblastic leukemia

MAY ADD as Medical Benefit for all Standard Formularies, including Medicaid

MAY ADD as Medical Benefit

Bontril® (phendimetrazine)

obesity MAY ADD with Prior Authorization for all Standard Formularies, including Medicaid (Group Specific Benefit)

MAY ADD with Prior Authorization (Group Specific Benefit)

Brineura™ Cerliponase alfa

symptomatic late infantile neuronal ceroid lipofuscinosis type 2

ADD as Medical Benefit with Prior Authorization

ADD as Medical Benefit with Prior Authorization

Cotempla XR-ODT™ (methylphenidate - extended-release orally disintegrating tablets)

attention deficit hyperactivity disorder

MAY ADD as Non-Formulary for all Standard Formularies, including Medicaid

MAY ADD with Step-Edit, Quantity Limits and Age criteria

diethylpropion obesity MAY ADD with Prior Authorization for all Standard Formularies, including Medicaid (Group Specific Benefit)

MAY ADD with Prior Authorization (Group Specific Benefit)

Pharmacy

April 2018 Pharmacy ChangesThese changes apply to plans with pharmacy benefits administered by Optima Health.

The purpose of the following is to communicate pharmacy changes effective April 1, 2018.Note: Pharmacy changes are made on a quarterly basis with effective dates of:

January 1, April 1, July 1, and October 1.*For Groups without a four-tier pharmacy plan, drugs listed as moving to Tier 4 will remain at Tier 3.

11

Drug Name Indication Description Change (Standard Formularies)

Description Change (Open Formularies)

Description Change (OHCC

Formulary)

Endari™ (L-glutamine powder)

short bowel syndrome/sickle cell disease

MAY ADD to specialty tier with Prior Authorization and quantity limit for all Standard Formularies, including Medicaid

MAY ADD to specialty tier with Prior Authorization and quantity limit

esomeprazole gastroesophageal reflux disease

ADD to all Standard Formularies, including Medicaid, remove Step-Edit

Remove Step-Edit

Fibrik (B-complex, vitamin E & folic acid 1mg)

suboptimal nutritional status

EXCLUDE from all Standard Formularies, including Medicaid

EXCLUDE from formulary

Gattex® (teduglutide (rDNA Origin) for Injection)

short bowel syndrome

UPDATE Prior Authorization criteria for all Standard Formularies, including Medicaid

UPDATE Prior Authorization criteria

Haegarda® (C1 esterase inhibitor human)

hereditary angioedema

MAY ADD Medical Benefit with Prior Authorization

MAY ADD Medical Benefit with Prior Authorization

Hetlioz® (tasimelteon)

non-24-hour sleep-wake disorder

MAY ADD to specialty tier with Prior Authorization for all Standard Formularies, including Medicaid

MAY ADD to specialty tier with Prior Authorization

Lialda® (mesalamine)

Crohn’s disease, ulcerative colitis

Move to Non-Preferred tier for Commercial Formularies

Move to Non-Preferred tier

Lomaira™ (phentermine)

obesity MAY ADD to Non-Preferred tier with Prior Authorization to Commercial and QHP formularies (Group Specific Benefit) MAY ADD as formulary with Prior Authorization to Medicaid Formulary

MAY ADD to Non-Preferred tier with Prior Authorization (Group Specific Benefit)

Mezparox-HC Forte (hydrocortisone-pramoxine)

minor pain, itching due to eczema, rash, minor burns, insect bites

EXCLUDE from all Standard Formularies, including Medicaid

EXCLUDE from formulary

Mydayis® (mixed salts of a single-entity amphetamine product)

attention-deficit hyperactivity disorder

Non-Formulary for all Standard Formularies, including Medicaid

MAY ADD with Step-Edit, Quantity Limits and Age criteria

Nexium® (esomeprazole)

gastroesophageal reflux disease

REMOVE Step-Edit and from all Standard Formularies, including Medicaid

REMOVE Step-Edit

providerNEWS Spring 2018

Pharmacy

12

Drug Name Indication Description Change (Standard Formularies)

Description Change (Open Formularies)

Description Change (OHCC

Formulary)

Non-Preferred CNS Stimulants (Adzenys XR-ODT™, Aptensio XR™, Daytrana®, Dynavel™ XR, Evekeo®, Quillichew® ER, Quillivant® XR)

attention deficit/hyperactivity disorder

UPDATE Step-Edit criteria, no change in formularies

UPDATE Step-Edit criteria, no change in formularies

Non-Preferred Human Growth Hormones (Genotropin®, Humatrope®, Saizen®, Serostim®, Zomacton™,Zorbtive®)

growth hormone, various indications

UPDATE Step-Edit criteria, no change in formularies

UPDATE Step-Edit criteria, no change in formularies

NutreStore® (L-glutamine powder for oral solution)

short bowel syndrome/sickle cell disease

EXCLUDE from all Standard Formularies, including Medicaid

EXCLUDE

Qudexy XR® (topiramate)

epilepsy and migraine prophylaxis

MAY ADD as Non-Formulary for all Standard Formularies, including Medicaid

MAY ADD with Prior Authorization

Regimex™ (benzphetamine)

obesity MAY ADD with Prior Authorization for all Standard Formularies, including Medicaid (Group Specific Benefit)

MAY ADD with Prior Authorization (Group Specific Benefit)

Revatio® Suspension (sildenafil)

pulmonary arterial hypertension

ADD with age limit for all Standard Formularies ADD with Prior Authorization for Medicaid

ADD with age limit

Rituxan Hycela® (rituximab and hyaluronidase)

antineoplastic MAY ADD as Medical Benefit with Prior Authorization for all Standard Formularies, including Medicaid

MAY ADD as Medical Benefit with Prior Authorization

Shingrix® (zoster vaccine, live)

shingles vaccine MAY ADD as formulary for all Standard Formularies, including Medicaid

MAY ADD as formulary

Simponi Aria® (golimumab)

moderate to severe rheumatoid arthritis

UPDATE Prior Authorization criteria for all Standard Formularies, including Medicaid

UPDATE Prior Authorization criteria

Syndros® oral solution, CII (dronabinol)

AIDS-related anorexia/chemotherapy-induced nausea/vomiting

ADD with Prior Authorization criteria and Transition of Care for all Standard Formularies, including Medicaid

ADD with Prior Authorization criteria and Transition of Care

Pharmacy

13

Drug Name Indication Description Change (Standard Formularies)

Description Change (Open Formularies)

Description Change (OHCC

Formulary)

Trokendi XR® (topiramate)

epilepsy and migraine prophylaxis

MAY ADD as Non-Formulary for all Standard Formularies, including Medicaid

MAY ADD with Prior Authorization

Urea Aero (urea foam 35%)

hyperkeratotic conditions

EXCLUDE from all Standard Formularies, including Medicaid

EXCLUDE from formulary

Uresol (urea cream 42.5%)

hyperkeratotic conditions

EXCLUDE from all Standard Formularies, including Medicaid

EXCLUDE from formulary

Valcyte® solution (valganciclovir)

cytomegalovirus ADD with age limit for all Standard Formularies ADD with Prior Authorization for Medicaid Formulary

ADD with age limit

Vecamyl® (mecamylamine hydrochloride)

hypertension EXCLUDE from all Standard Formularies, including Medicaid

MAY ADD with Prior Authorization

Xeljanz®/Xeljanz® XR (tofacitinib citrate)

active psoriatic arthritis

ADD criteria for new indication ADD criteria for new indication

Zelapar™ ODT (selegeline)

Parkinson’s disease/major depressive disorder

MAY ADD with Step-Edit to all Standard Formularies, including Medicaid

MAY ADD with Step-Edit

providerNEWS Spring 2018

On rare occasions, updates are made between content submission deadlines and newsletter publication dates. For the most current list of pharmacy changes, please visit the drug lists section under “Pharmacy” on optimahealth.com/providers.

Pharmacy

14

Medication Linked to Falls

Review medications with all patients age 65 and older. Medication management can reduce interactions and side effects that may lead to falls.

• STOP medications when possible.• SWITCH to safer alternatives.• REDUCE medications to the lowest effective dose.

Check for psychoactive medications such as anticonvulsants, antidepressants*, antipsychotics,benzodiazepines, opioids, and sedatives-hypnotics*.

Review prescription drugs, over-the-counter medications, and herbal supplements. Some can cause dizziness, sedation, confusion, blurred vision, or orthostatic hypotension. These include anticholinergics, antihistamines, medications affecting blood pressure, and muscle relaxants.

Develop a patient plan that includes medication changes, and a monitoring plan for potential side effects. Implement other strategies, including non-pharmacologic options to manage conditions, address patient barriers, and reduce fall risk.

Review the American Geriatrics Society Beers Criteria for more information on medications linked to falls.

The Centers for Disease Control and Prevention’s STEADI tools and resources can help you screen, assess, and intervene to reduce your patient’s fall risk. For more information, visit cdc.gov/steadi.

*Antidepressants include TCAs and SSRIs. Sedative-hypnotics include Eszopiclone, Zaleplon, and Zolpidem.

Source: Centers for Disease Control and Prevention, 2018.

Clinical Guidelines

Optima Health reviews and revises clinical guidelines bi-annually. The most up-to-date, evidenced–based clinical guidelines can be found in the Clinical Reference section of optimahealth.com/providers. If you would like a printed copy of these guidelines or have questions, comments, or suggestions about the guidelines, please contact the Optima Health Quality Improvement Department at757-252-8400 or 1-844-620-1015.

Please note: Clinical data in a particular case may necessitate or permit deviation from these guidelines. Optima Health guidelines are institutionally endorsed recommendations and not intended as a substitute for clinical judgment.

Quality Improvement

15

HEDIS® and Medication Management in the Elderly

Prescription drug use by the elderly can often result in adverse drug events that contribute to hospitalization, increased duration of illness, nursing home placement, falls, and fractures. Despite widely accepted medical consensus that certain drugs increase the risk of harm to the elderly1, these drugs continue to be prescribed. Because older adults are more likely to take multiple medications for multiple conditions, they are also at higher risk of potentially harmful drug-disease interactions. Avoiding the use of high-risk drugs is an important, simple, and effective strategy to reduce medication-related problems and adverse drug events in older adults.2

Related HEDIS®3 Measures:

• Potentially Harmful Drug-Disease Interactions in the Elderly: Assesses adults 65 and older who have a specific disease or condition (chronic renal failure, dementia, history of falls) and were dispensed a prescription for a medication that could exacerbate it.

• Use of High-Risk Medications in the Elderly: Assesses adults 65 and older who had at least one dispensing event for a high-risk medication or who had at least two dispensing events for the same high-risk medication.

For more information, visit the Additional Information section at the bottom of the Formularies and Drug Lists page from the Pharmacy section of optimahealth.com/providers.

1 Fick, D.M., et al.2003. “Updating the Beers criteria for potentially inappropriate medication use in older adults.” Arch Intern Med 163:2716–24.2 Radcliff, S., Yue, J., Rocco, G., Aiello, S.E., Ickowicz, E., Hurd, Z., Samuel, M.J. and Beers, M.H. 2015. “American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults.” Journal of the American Geriatrics Society, 63(11): 2227-2246.3 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Source: National Committee for Quality Assurance (2017). HEDIS 2018. Technical Specifications. Vol. 2 (pp. 256-257). Washington, D.C.

providerNEWS Spring 2018

HEDIS® 2018 (CY2017) Update

In order to meet NCQA’s timeline for submission of all HEDIS® data, Optima Health must complete all data collection and on-site medical record reviews by May 2, 2018.

The Quality Improvement (QI) Department thanks you in advance for your cooperation. For additional information on HEDIS® Measures, or the Medical Record Review process, please contact the QI Department at 757-252-8400 or 1-844-620-1015.

Quality Improvement

16

Annual Provider Notices

At Optima Health, we want to make sure our providers are informed healthcare consumers.

Our Annual Provider Notice provides information about what to do in certain situations, and who to contact when services are needed, or when there are questions. The Annual Provider Notice can be found in the Clinical Reference section of optimahealth.com/providers.

Member Rights and Responsibilities

The Optima Health Member Bill of Rights and Responsibilities ensures that all members are treated in a manner consistent with the mission, goals, and objectives of Optima Health.

It also ensures that providers are aware of theirobligations and responsibilities upon joiningOptima Health, and throughout their participationwith the Plan.

This information is available in the Optima HealthProvider Manual.

To view this information online:

• visit optimahealth.com/members,

• select Manage My Plan, then

• select Member Rights and Responsibilities.

Quality Improvement

providerNEWS Spring 2018

17

Keep Your Practice Information Up to Date

Please notify Optima Health of any changes to provider or practice information with 60 days’ notice, or as soon as possible, especially changes to:

• provider rosters,

• panel status,

• address/phone numbers, and

• practice email address for official communication from Optima Health.

Medical providers should contact their Network Educator at 1-877-865-9075 with this information; Behavioral Health providers should complete the Behavioral Health Provider Update Form.

Thank you for your partnership in providing accurate information to our members!

Important Phone Numbers

Provider Relations 757-552-7474 or 1-800-229-8822

OHCC:1-844-512-3172

Provider Relations Fax 757-961-0565

Behavioral Health Provider Relations 757-552-7174 or 1-800-648-8420

Medical Care Management(Pre-Authorization)

757-552-7540 or 1-800-229-5522

OHCC:1-866-546-7924

Network Educators 757-552-7085 or 1-877-865-9075

Health and Preventive Services 757-687-6000

Proprium Pharmacy 1-855-553-3568

Proprium Pharmacy Fax 1-844-272-1501